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Abstract
Background -Jet nubulisers and metered dose inhalers are widely used to deliver aerosolised drugs to the lungs ofintubated patients in adult intensive care units. Drug delivery using these systems has been shown to be inefficient and both forms of delivery have the potential to induce paradoxical bronchoconstriction in patients with reactive airways disease. Methods -Experiments were carried out to determine whether it was possible to deliver drug from a dry powder delivery system through an endotracheal tube. A 200 ig budesonide Turbohaler was enclosed in a chamber which allowed it to be inserted into a ventilator circuit. Experiments were performed with a multistage liquid impinger in which drug was drawn through the Turbohaler and endotracheal tube at 60 Vmin providing an index of the maximum drug delivery achievable via this route. A second series of experiments was performed in which the Turbohaler was placed in a ventilator circuit using a Servo 900C volume cycled ventilator. Drug delivered from the Turbohaler during the inspiratory phase was collected on a filter placed between the end of a 9 mm endotracheal tube and a model lung. A tidal volume of 500 ml and inspiratory time of 0*5 seconds was used.
Budesonide was assayed using an ultraviolet spectrophotometric assay. Jet nebulisers have traditionally been used in adult intensive care units when administering drugs via endotracheal tubes to the lower airways of intubated patients.l More recently, many centres -particularly in North America -have been using metered dose inhalers for this purpose.5 It has been known for some time that the effective drug delivery from conventional jet nebulisers is generally low due to factors such as raining out of drug in the ventilator,l" while other problems such as cooling of the inspired air, adding gas volume to the ventilator circuit, and poor reproducibility of output have been cited as reasons for considering alternative systems.5710 Both dosimetric jet nebulisers, which deliver drug only during inspiration," and ultrasonic nebulisers 2 have been shown in in vitro studies to be capable ofdelivering significantly greater doses, but they have not been widely accepted and no deposition studies have been performed to confirm their promise. Comparisons ofmetered dose inhaler and jet nebuliser based systems in the intensive care setting have produced conflicting results, with some indicating improved drug delivery using metered dose inhaler systems7 and some improved delivery with jet nebulisers.'3 Reviewing the evidence, it would appear that both metered dose inhaler and jet nebuliser systems, if suitably chosen and used optimally, can deliver therapeutic doses to the lungs of intubated patients, and that the main impetus in North America to move towards the metered dose inhaler based systems is the financial saving, principally in respiratory technologist time, that such systems provide.568
One problem common to aerosols generated by both wet nebuliser and metered dose inhaler systems is the ability of the aerosol to induce bronchoconstriction in those with obstructive airways disease.'415 The potential for inducing such events in some severely ill asthmatic patients in the intensive care setting is of some concern.
A series of in vitro experiments was performed to determine whether it is possible to deliver budesonide, in the form ofa dry powder, via endotracheal tubes using a Turbohaler and a novel adapter for use in ventilator circuits.
Methods
Budesonide Turbohalers, 200 jig, were used for these experiments. The standard Turbohaler mouthpiece was modified by cutting back the outer covering to reveal the inner cylinder containing the spiral disaggregation channels, which could then be inserted into the end of an endotracheal tube. The Turbohaler was enclosed in a chamber or "spaceship" (Astra Draco, Lund, Sweden) which permits air to flow through the Turbohaler and out via the mouthpiece (fig 1) . The "spaceship" permits loading of the dosing channels without removing it from the device. Uncut 32 cm straight endotracheal tubes (Portex, Hythe, UK) with an internal diameter of 9 mm were used for all the experiments.
Initial experiments (n = 6) were performed in which an Astra multistage liquid impinger (Copley, Nottingham, UK) was used to assess both the quantity of drug and particle size distribution of the drug particles. The Turbohaler with the endotracheal tube attached was inserted into the inlet of the multistage liquid impinger and air was drawn through the system at a rate of 60 1/min. When inflated, the endotracheal tube cuff provided a good seal when inserted into the inlet of the multistage liquid impinger, ensuring that the entire air flow (60 1/min) passed through the Turbohaler. Further experiments (n= 15) were then performed with the Turbohaler placed in a ventilator circuit between the manifold and endotracheal tube as shown in fig 2. Drug delivered via the endotracheal tube was collected on a filter (Kendall Curity anaesthesia filters) placed between the end of the tube and a model lung. A Servo 900C (Siemens, Sweden) ventilator was used with the tidal volume set at 500 ml and an inspiratory time of 0-5 seconds. A total of ten actuations were used for each experiment to ensure adequate quantities of drug on the filter. The pause button on the ventilator permits the Turbohaler to be loaded between inspiratory flows and potentially allows a pause for breath holding at the end of inspiration.
Each filter was washed with 100 ml ofethanol and the budesonide was measured using a spectrophotometric method.
Results
The mean (SD) total dose from the standard Turbohaler including that retained on the Figure 3 illustrates the pattern of powder deposition at the proximal end of the endotracheal tube following multiple actuations, illustrating that the powder continues to spiral after leaving the mouthpiece.
Discussion
These results suggest that drug from dry powder delivery systems can be delivered efficiently via endotracheal tubes and that such systems may be valuable in the intensive care setting. Results with the multistage liquid impinger indicate that as much as 30% of the nominal dose can be delivered via an endotracheal tube. Although the total dose on stages 3 and 4 is reduced compared with the standard Turbohaler, these results also suggest that the tubing is particle selective in that the ratio of drug on stages (3 +4) 
